REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
NCT00485069
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Parkinson's Disease
Interventions
DRUG:
ROP
DRUG:
ROP+L-Dopa
Sponsor
GlaxoSmithKline